Sue Currie Email and Phone Number

She has 20+ years of strategic, operational, and scientific leadership experience in clinical research and development programs, from the discovery phase to post-launch, with a focus on cancers and infectious diseases. Prior to joining Virion, she was Vice President, Head of Medical Affairs, at Nektar Therapeutics where she had responsibilities that included global executive and corporate leadership roles within the Company and was a core member of the Research and Development senior leadership team. Dr. Currie has biotech organizational leadership experience, but also has been instrumental in the study design and strategies for clinical programs, as well as the scientific analyses and dissemination of these data, in various forums. In this element, she has experience developing and building out new clinical functions and teams, including medical affairs and other related activities. Prior to Nektar, Dr. Currie held Senior positions at Genentech/Roche and Health Interactions, the latter of which she oversaw all US Operations and a team of almost 200 persons. She has authored numerous pivotal scientific publications in both immuno-oncology, as well as infectious diseases, including HIV, HCV, and Coinfection treatment guidelines. Additionally, she has been a leader in external and internal health educational global and national programs and clinical resources for healthcare providers and other stakeholders in hepatitis and liver diseases, as well as oncology.Sue brings with her a patient-centric focus to her operational and clinical leadership, from her Veterans Health Administration, academic, correctional health, and community care setting experiences.Virion Therapeutics, LLC, is a science-driven company whose mission is to cure cancer and chronic infectious diseases through the development of novel and accessible CD8+ T cell-based immunotherapies. For more info: www.VirionTx.com

Strategic scientific communications lead for all CIT Lung communications activities. Included oversight of all global scientific dissemination and communications for congresses, publications, development and dissemination of training and related materials for both internal and external stakeholders, as well as 2 recent approvals (FDA and/or EMA). Core member of life cycle team, and related activities.

Health Interactions is a Global Medical Communications company with a number of locations in the US and around the world. In my role, as SVP, I led all medical communications activities and services, across therapy areas, with pharma / biotech partners, on products from early pipeline through post-launch (i.e. cancer immunotherapy, biomarkers, liver disease, women's health, immunology and rare diseases). In addition to strategic support of medical and publications strategies, I was involved in clinical operations strategies and tactics, including working with CROs, regulatory bodies, investigator engagements, internal and external (i.e. field) training, medical information and education, congress activities, product commercialization, business development , and payors. At Health Interactions (HI), I successfully: *recruited, mentored and retained a multi-functional, geographically diverse global healthcare team (i.e. MDs, PhDs, PharmDs, Account Services, & Others)*implemented quality control strategies and processes, across therapeutic areas & teams, to maximize efficiencies and proactively address issues, to achieve strategic goals & objectives*supported the company's growth by 285% in 3 fiscal years*supported and facilitated a number of drugs in development from early pipeline, through to launch